tirzepatide reactive hypoglycemia PDF) Use of for Severe in a Patient with Obesity Unveiling the Therapeutic Potential of
Description
[DOI] [PubMed] [Google Scholar] [13].Fras JP, Davies MJ, Rosenstock J, et al

J Am Coll Cardiol 2025;85:699706

Conclusions: Tirzepatide can induce hypoglycemic ketoacidosis in nondiabetic patients with obesity when used for weight reduction

Abbott, Eli Lilly, Lusofarmaco, Novo Nordisk, Sanofi (support for attending meetings or travels)

10.1111/dom.14882 48 ZhengY.LeyS

Both semaglutide and tirzepatide have proven to help people lose up to 15 to 20% of their body weight